Typ : |
tidningen |
internet länkar : |
http://www.currenttherapeuticres.com/article/S0011-393X(15)00016-8/abstract |
|
forskargrupper : |
San Francisco - Theravance Biopharma |
Författare : |
Gu Z, Parra C, Wong A, Nguyen A, Cheung R, Catalano T. |
Titel : |
Post-reconstitution Stability of Telavancin with Commonly Used Diluents and Intravenous Infusion Solutions. |
Hänvisningar : |
Current Ther Res ; 77: 105-110. 2015 |
|
Evidensgrad : |
|
fysikalisk stabilitet : |
|
kemisk stabilitet : |
|
andra metoder : |
|
Kommentarer : |
Nedbrytningsprodukter identifierade och kvantifierade |
|
Förteckning över substanser
Telavancin hydrochloride
|
|
|
|
|
15 mg/ml |
2-8°C |
|
7 |
|
|
|
|
|
|
15 mg/ml |
20-25°C |
|
12 |
|
|
|
|
|
|
15 mg/ml |
2-8°C |
|
7 |
|
|
|
|
|
|
15 mg/ml |
20-25°C |
|
12 |
|
|
|
|
|
|
0.6 mg/ml |
2-8°C |
|
7 |
|
|
|
|
|
|
0.6 mg/ml |
20-25°C |
|
12 |
|
|
|
|
|
|
8 mg/ml |
2-8°C |
|
7 |
|
|
|
|
|
|
8 mg/ml |
20-25°C |
|
12 |
|
|
|
|
|
|
0.6 mg/ml |
2-8°C |
|
7 |
|
|
|
|
|
|
0.6 mg/ml |
20-25°C |
|
12 |
|
|
|
|
|
|
8 mg/ml |
2-8°C |
|
7 |
|
|
|
|
|
|
8 mg/ml |
20-25°C |
|
12 |
|
|
|
|
|